Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study
Thomas Benfield(University of Copenhagen), Hanne Rolighed Christensen(Frederiksberg Hospital), Marie Helleberg(Rigshospitalet), Lars Haukali Omland(Copenhagen University Hospital), Rajesh Mohey(Regionshospitalet Herning), Claire Holm(Frederiksberg Hospital), Christian Niels Meyer(UniQure (Netherlands)), Işık Somuncu Johansen, Christian Brieghel(Copenhagen University Hospital), Zitta Barrella Harboe(Statens Serum Institut), Jonathan Starling(Copenhagen University Hospital), Tomas Ø. Jensen(Copenhagen University Hospital), Ole S. Søgaard(Aarhus University Hospital), Haakon Sandholdt(Copenhagen University Hospital), Torben Tranborg(Bispebjerg Hospital), Lars Pedersen(Bispebjerg Hospital), Birgitte Lindegaard(University of Copenhagen), Stine Johnsen(Harvard University), Christian Søborg(Gentofte Hospital), Henrik Nielsen(Aalborg University Hospital), Niels Obel(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Merete Storgaard(Aarhus University Hospital), Stig Lønberg Nielsen(University of Southern Denmark), Jacob Bodilsen(Aalborg University Hospital), Pernille Ravn(Herlev Hospital), Daria Podlekareva(University of Copenhagen), Birgitte Klindt Poulsen(Aalborg University Hospital), Lothar Wiese(Zealand University Hospital), Janne Jensen(Kolding Hospital), Simone Bastrup Israelsen(Copenhagen University Hospital)
Cited by 93